MilliporeSigma to Build Two Biodevelopment Facilities in U.S. and China

12 Jan 10 Jan, 2017

Millipore will open two new Provantage End-to-End services centers in Boston and Shanghai. These centers will capitalize on the success of the center in Martillac, France, a fully operational, single-use, GMP facility. The two facilities will provide a range of process development services, including cell-line, upstream and downstream, and non-GMP clinical production. Provantage services provided by the Martillac facility currently include: biopharma process development, clinical-scale templates, GMP clinical supply solutions, facility design and construction consultation, and process scale-up and technical transfer services.

Leave a Reply

Your email address will not be published. Required fields are marked *